Investor Relations

Investor Contact Information

Company

TNF Pharmaceuticals, Inc.
855 N. Wolfe Street
Suite 601
Baltimore, MD 21205

Investor Relations

Robert Schatz
T: 646-421-9523
rschatz@tnfpharma.com

Transfer Agent

Securities Transfer Corporation
2901 N Dallas Parkway
Suite 380
Plano, Texas 75093
https://stctransfer.com

  • This field is for validation purposes and should be left unchanged.